HIRONORI HOZOJI
Profile
First Name
Middle Name
Last Name
Related Companies
Titles
Company Name
Related People
DIRECTOR
TOSHIO ASANO,
PHILIPPE CHAMBON,
JOHN COSTANTINO,
GEORG NEBGEN,
NAOYUKI ONO,
THONG YUEN POON,
THONG-YUEN POON,
GARY SHEARMAN,
GARY D. SHEARMAN,
MINORU TAKADA,
JEFFREY D. WAGER
DIRECTOR
BEN AUSPITZ,
DONALD BEEMAN,
DONALD P. BEEMAN,
C. BOYD CLARKE,
J. DONALD DEBETHIZY,
J. DONALD DEBETHIZY, PH.D.,
MARKUS GOEBEL,
MARKUS GOEBEL, M.D., PH.D.,
ROB GOODWIN,
ROBERT GOODWIN,
GEORGE KEMBLE,
GEORGE KEMBLE, PH.D.,
LARRY MIKKOLA,
IVOR ROYSTON,
IVOR ROYSTON, M.D.
DIRECTOR
GUIDO BAECHLER,
MICHAEL BELL,
HEINER DREISMANN,
PHILIPPE GOIX,
PHILIPPE J. GOIX,
CARL GORDON,
CARL L. GORDON,
GREGORY JOHNSON,
GREGORY R. JOHNSON,
ANDRE MARION,
R. DOUGLAS NORBY,
STEPHEN ROSE,
STEPHEN L. ROSE,
FRED VOGT,
FRED K. VOGT
DIRECTOR
BONNE ADAMS,
PATRICIA L. BITAR,
JOHN R. BOLTON,
JAMES E. CANTRELL,
WILLIAM COMER,
KENJI HARADA,
TIMOTHY M. HOFER,
MYOUNG-OK KWON,
WILLIAM LARUE,
BRYAN LEIGH,
BERTRAND C. LIANG,
J. JAY LOBELL,
H CASEY LOGAN,
MARTIN MATTINGLY,
SHARON REAL,
CHARLES P. THEUER,
J. RAINER TWIFORD,
PAUL WALKER,
TED WANG,
STEPHEN WORLAND
DIRECTOR
NATHANIEL DAVID,
DENNIS FENTON,
KEITH KLEIN,
FRANCOIS KRESS,
KEITH LEONARD,
ROBERT NELSEN,
CAMILLE SAMUELS,
DAVID SCHNELL,
JOHN SMITHER,
JOSEPH TURNER,
PATRICIA WALKER
DIRECTOR
BARBARA DALTON,
PETER GREBOW,
KENJI HARADA,
DIANE JORKASKY,
BERNARDUS N. MACHIELSE,
CARTER MEYER,
I. WISTAR MORRIS,
DAVID MOTT,
SARA M. NAYEEM,
GILLES M. NOBECOURT,
FEDERICA O-BRIEN,
FREDERICA O-BRIEN,
H. JOSEPH REISER,
HAROLD SAFFERSTEIN,
FRANCISCO D. SALVA,
JOSHUA M. TARNOFF,
MIWA TOYODA
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2014-05-30
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity, Debt
2012-06-21
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2012-02-17
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2011-08-30
D/A
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity, Debt
2011-05-06
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Debt
2011-06-07
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity, Debt
2011-05-06
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2011-03-28
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2010-07-14
D/A
PHARMACEUTICALS
DECLINE TO DISCLOSE
Debt
2010-04-09
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Debt
2010-04-09
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2010-02-25
D/A
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2009-04-28
D/A
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2008-03-18
D
BIOTECHNOLOGY
NO REVENUES
Debt
2009-04-28
